EquiVac Innovator EHV-1/4

Equine Rhinopneumonitis Vaccine

Killed Virus

For vaccination of healthy horses 10 months of age or older as an aid in the prevention of equine rhinopneumonitis due to type 1 and 4 viruses.

For Veterinary Use Only

DOSE: Horses, inject one 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 4 weeks after the first dose. A 1 mL booster dose should be given annually.

EquiVac Innovator EHV-1/4 Caution

Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine.

Thimerosal, neomycin and polymyxin B added as preservatives.

U.S. Vet. License No. 190

Zoetis Inc., Kalamazoo, MI 49007, USA

CPN: 3690283.3